NASDAQ: QNCX
Quince Therapeutics Inc Stock Ownership - Who owns Quince Therapeutics?

Insider buying vs selling

Have Quince Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Luca BenattiDirector2025-12-2650,000$3.47
$173.50kSell
Brendan HannahCBO COO CCO2025-12-052,271$0.55
$1.25kBuy
Brendan HannahCBO COO CCO2025-12-0525,280$0.94
$23.76kBuy

1 of 1

QNCX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when QNCX insiders and whales buy or sell their stock.

QNCX Shareholders

What type of owners hold Quince Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Epiq Capital Group LLC2,237.13%22,753,059$618.20MInsider
David Lamond431.05%4,384,096$119.12MInsider
Pierre Lamond283.81%2,886,530$78.43MInsider
Pfizer Inc283.17%2,879,973$78.25MInsider
Takeda Ventures Inc263.48%2,679,802$72.81MInsider
Stephen S. Dominy141.36%1,437,674$39.06MInsider
Casey Lynch116.08%1,180,580$32.08MInsider
Dirk Thye97.82%994,885$27.03MInsider
Philip S. Low51.06%519,283$14.11MInsider
Brendan Hannah35.58%361,827$9.83MInsider

1 of 3

QNCX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNCX0.00%100.00%Net Selling
IGC0.01%24.95%Net BuyingNet Buying
EVAX0.00%5.19%
QNTM0.01%0.00%
CVM0.01%52.55%Net BuyingNet Buying

Quince Therapeutics Stock Ownership FAQ

Who owns Quince Therapeutics?

Quince Therapeutics (NASDAQ: QNCX) is owned by 0.03% institutional shareholders, 4,050.93% Quince Therapeutics insiders, and 0.00% retail investors. Epiq Capital Group LLC is the largest individual Quince Therapeutics shareholder, owning 22.75M shares representing 2,237.13% of the company. Epiq Capital Group LLC's Quince Therapeutics shares are currently valued at $614.56M.

If you're new to stock investing, here's how to buy Quince Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.